Founded in 2000, Landing Med’s mission is to use AI technology to eliminate cancer. We focus on developing early cancer detection technology solutions for pathologists, hospitals and governments. Backed by Alibaba Health and Bank of China Investment Group, Landing Med’s AI+Cloud diagnostic database consists of 10+ million samples and we partner with 1000+ health organizations globally to deliver intelligent, efficient and accessible solutions.